Tirzepatide , used in Zepbound and Mounjaro, is a dual-action therapy that may deliver stronger or faster results for individuals with insulin resistance or prior treatment resistance
Food & Drug Administration standards for sharps containers
Helps improve athletic performance, endurance, and daily activity
This is typically prescribed for patients who require additional glycemic control and weight loss
Check with your doctor immediately if any of the following side effects occur: More common Diarrhea stomach pain Less common Difficulty in breathing or swallowing fast heartbeat gaseous stomach pain heartburn recurrent fever skin itching, rash, or redness stomach fullness swelling of the face, throat, or tongue vomiting yellow eyes or skin Incidence not known Anxiety bloating blurred vision change in vision changes in behavior chest tightness chills cold sweats coma confusion constipation cool, pale skin cough darkened urine depression dizziness dry mouth fast heartbeat fever increased hunger indigestion large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs loss of appetite nausea nervousness nightmares pains in the stomach, side, or abdomen, possibly radiating to the back puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue seizures shakiness slurred speech sunken eyes thoughts of harming oneself unusual tiredness or weakness wrinkled skin Some side effects may occur that usually do not need medical attention
Eur J Hum Genet 2010;18:1160-5
